Interestingly, the p230 isoform was found to comprise a distinct clinical entity called neutrophilic CML, with a more benign clinical course than that associated with the p210 and p190 isoforms [8]. This evidence concerns the gene EVPL and chronic myelogenous leukemia, BCR-ABL1 positive.